Neoadjuvant and first-line (1L) metastatic dosing and administration guidelines

See the different treatment regimens, dose modifications, and administration guidelines for PERJETA-based treatment

Neoadjuvant treatment regimens

1L metastatic treatment regimen

Request more information

Genentech Clinical Oncology Specialists are available to answer your questions about PERJETA.

Sign up for updates from Genentech

Receive emails with news and information about PERJETA and other Genentech products.